Novo Integrated Sciences Inc. (NASDAQ:NVOS) Stock Soars 78% in a Week: Here is Why
There were a number of companies that kicked off the new week with strong performances from their stocks, and one of those to have been there was Novo Integrated Sciences Inc. (NASDAQ:NVOS). The company seemed to have come under considerable focus among investors, and its stock ended up with gains of as much as 34% amidst heavy action. In light of the gains made by the stock yesterday, it may be a good time to take a closer look at Novo Integrated.
The company had been in the news on August 15 when it made an announcement with regards to a number of updates about some actions and events. The company announced that parties continued to work on the previously announced share purchase agreement with SwagCheck Inc. and its shareholders. As per the agreement, the company had agreed to pick up 100% of all the outstanding shares of SwagCheck.
The company had previously entered into a securities purchase agreement with RC Consulting Group in favor of SCP Tourbillion Monaco. As per the agreement, an unsecured 15-year promissory note was issued to the RC Noteholder with the principal sum of $70000000. The sum represented $57,000,000 and a yield of 1.52 dollars a year. In the announcement on August 15, the company announced that it expected that the initial draw of $57,000,000 would go to it in the near term.
Another update from the company was with regard to the fact that its board of directors had initiated a strategic review to look into the possibility of launching a share repurchase program. In the past, it had been announced that Novo Integrated had been provided with a funding commitment to the tune of $40,000,000 in direct investment by way of Gulf International Minerals and Energy Group (GIMEG) from Sheikh Khaled bin Mohammad bin Fahad Al Thanayan. In the latest update from the company, it was announced that the project was going to fund joint ventures with Novo Integrated, like elder living properties in Canada. That particular project was active and in the initial stages of development.
On July 17, the company came into the news cycle after it made an announcement with regard to its financial results for the third fiscal quarter, which ended on May 31, 2023. At the end of the quarter, the company had cash and cash equivalents to the tune of $464,011; its total assets came in at $35.7 million, while the total liabilities stood at $9.5 million.
Revenues slumped by as much as 76% year on year to drop to $3,292,933 from $13,851,833 in the prior-year period. The sharp drop in revenues had primarily been brought about by the drop in outsourced product sales and IoNovo Iodine. The net losses for the quarter stood at $1,497,330, and that worked out to a drop of as much as 61% from the net losses of $3,810,054 in the prior-year period. The drop in operating expenses was mainly the reason behind the drop in net losses.
